FDA Inspection 891189 — Merck Serono S.p.A.

Merck Serono S.p.A. — FEI 3003581732

The FDA completed an inspection of Merck Serono S.p.A. on July 1, 2014 in Modugno. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 5 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 1, 2014
Fiscal Year
2014
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Modugno (Italy)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
119421 CFR 211.42(c)Defined areas of adequate size for operations
139521 CFR 211.103Actual vs. theoretical yields not determined
195721 CFR 211.180(e)(2)Review of problem drugs
356521 CFR 211.58Buildings not maintained in good state of repair